Registro:

Referencias:

• Ghezzi, P., Brines, M., Erythropoietin as an antiapoptotic, tissue-protective cytokine (2004) Cell Death Differ., 11 (SUPPL. 1), pp. S37-S44
• Ehrenreich, H., Aust, C., Krampe, H., Jahn, H., Jacob, S., Herrmann, M., Sirén, A.-L., Erythropoietin: novel approaches to neuroprotection in human brain disease (2004) Metab. Brain Dis., 19, pp. 195-206
• Um, M., Lodish, H.F., Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signalling pathways (2006) J. Biol. Chem., 281, pp. 5648-5656
• Chen, Z.-Y., Asavaritikrai, P., Prchal, J.T., Noguchi, C.T., Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation (2007) J. Biol. Chem., 282, pp. 25875-25883
• Silva, M., Grillot, D., Benito, A., Richard, C., Nunez, G., Fernandez-Luna, J.L., Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2 (1996) Blood, 88, pp. 1576-1582
• Pregi, N., Vittori, D., Perez, G., Leirós, C.P., Nesse, A., Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells (2006) Biochim. Biophys. Acta, 1763, pp. 238-246
• Kretz, A., Happold, C.J., Marticke, J.K., Isenmann, S., Erythropoietin promotes regeneration of adult CNS neurons via Jak2/AKT pathway activation (2005) Mol. Cell. Neurosci., 29, pp. 569-579
• Chen, G., Shi, J.X., Hang, C.H., Xie, W., Liu, J., Liu, X., Inhibitory effects on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (RHUEPO) (2007) Neurosci. Lett., 425, pp. 177-182
• Aggarwal, B.B., Signalling pathways of the TNF superfamily: a double-edged sword (2003) Nat. Rev. Immunol., 3, pp. 745-756
• Hehlgans, T., Pfeffer, K., The intriguing biology of the tumor necrosis factor/tumor necrosis factor receptor superfamily: players, rules and the games (2005) Immunology, 115, pp. 1-20
• Tucker, S.J., Rae, C., Littlejon, A.F., Paul, A., MacEwan, D.J., Switching leukemia cell phenotype between life and death (2004) Proc. Natl. Acad. Sci., 101, pp. 12940-12945
• Varfolomeev, E.E., Ashkenazi, A., Tumor necrosis factor: an apoptosis JunKie? (2004) Cell, 116, pp. 491-497
• Jupp, O.J., McFarlane, S.M., Anderson, H.M., Littlejohn, A.F., Mohamed, A.A., MacKay, R.H., Vandenabeele, P., MacEwan, D.J., Type II tumor necrosis factor-α (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways (2001) Biochem. J., 359, pp. 525-535
• Baker, D., Butler, D., Scallon, B.J., O, J.K., Neill, Turk, J.L., Feldmann, M., Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins (1994) Eur. J. Immunol., 24, pp. 2040-2048
• Sirén, A.L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Ghezzi, P., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 4044-4049
• Agnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M.L., Ghezzi, P., Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis (2002) Brain Res., 952, pp. 128-134
• Brines y, M., Cerami, A., Emerging biological roles for erythropoietin in the nervous system (2005) Nat. Rev. Neurosci., 6, pp. 484-494
• Lowry, O.H., Protein measurement with the folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275
• Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63
• Vittori, D., Pregi, N., Pérez, G., Garbossa, G., Nesse, A., The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminium exposure through mechanisms involving erythropoietin receptor (2005) Biochim. Biophys. Acta, 1743, pp. 29-36
• Laemmli, U.K., Amos, L.A., Klug, A., Correlation between structural transformation and cleavage of the major head protein of T4 bacteriophage (1976) Cell, 7, pp. 191-203
• Chomczynski, P., Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction (1987) Anal. Biochem., 162, pp. 156-159
• Benito, A., Silva, M., Grillot, D., Núñez, G., Fernández-Luna, J.L., Apoptosis induced by erythroid differentiation of human leukaemia cell lines is inhibited by Bcl-xL (1996) Blood, 87, pp. 3837-3843
• McKinney, M., Robbins, M., Chronic atropine administration up-regulates rat cortical muscarinic m 1 receptor mRNA molecules: assessment with the RT/PCR (1992) Brain Res. Mol. Brain Res., 12, pp. 39-45
• Yang, L., Lindholm, K., Konishi, Y., Li, R., Shen, Y., Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways (2002) J. Neurosci., 22, pp. 3025-3032
• Thorburn, Death receptor-induced cell killing (2004) Cell Signal., 16, pp. 139-144
• Socolovsky, M., Fallon, A.E., Wang, S., Brugnara, C., Lodish, H.F., Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction (1999) Cell, 98, pp. 181-191
• Chong, Z.Z., Kang, J.-Q., Maiese, K., Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt, Bad, and caspase-mediated pathways (2003) Br. J. Pharmacol., 138, pp. 1107-1118
• Thommesen, L., Lægreid, A., Distinct differences between TNF receptor 1- and TNF Receptor 2-mediated activation of NFκB (2005) J. Biochem. Mol. Biol., 38, pp. 281-289
• Nicolas, O., Gavin, R., Braun, N., Ureña, J.M., Fontana, X., Soriano, E., Aguzzi, A., del Río, J.A., Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion (2007) FASEB J., 21, pp. 3107-3117
• Bittorf, T., Büchse, T., Sasse, T., Jaster, R., Brock, J., Activation of the transcription factor NF-κB by the erythropoietin receptor. Structural requirements and biological significance (2001) Cell Signal., 13, pp. 673-681
• Chong, Z.Z., Li, F., Maiese, K., Erythropoietin requires NF-κB and its nuclear translocation to prevent early and late apoptotic neuronal injury during β-amyloid toxicity (2005) Curr. Neurovasc. Res., 2, pp. 387-399
• Digicaylioglu, M., Lipton, S.A., Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades (2001) Nature, 412, pp. 641-647
• Micheau, O., Tschopp, J., Induction of TNF Receptor I-mediated apoptosis via two sequential signalling complexes (2003) Cell, 114, pp. 181-190
• Krueger, A., Baumann, S., Krammer, P., Kirchhoff, S., FLICE-Inhibitory proteins: regulators of death receptor-mediated apoptosis (2001) Mol. Cell. Biol., 21, pp. 8247-8254
• Rafiee, P., Shi, Y., Su, J., Pritchard, K.A., Tweddell, J.S., Baker, J.E., Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways (2005) Basic Res. Cardiol., 100, pp. 187-197
• Akhtar, R.S., Ness, J.M., Roth, K.A., Bcl-2 family regulation of neuronal development and neurodegeneration (2004) Biochim. Biophys. Acta, 1644, pp. 189-203
• Maiese, K., Li, F., Chong, Z.Z., Erythropoietin in the brain: can the promise to protect be fulfilled? (2004) Trends Pharmacol. Sci., 25, pp. 577-583
• Baeuerle, P.A., Baltimore, D., NF-kappa B: ten years after (1996) Cell, 87, pp. 13-20
• Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K., Eisel, U.M.L., Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation (2004) J. Biol. Chem., 279, pp. 32861-32881
• Taoufik, E., Petit, E., Divoux, D., Tseveleki, V., Mengozzi, M., Roberts, M., Valable, S., Probert, L., TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 6185-6190

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------